YMYomna Ibrahim Mahmoud

Yomna Ibrahim Mahmoud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yomna Ibrahim Mahmoud has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Flaxseed lignans alleviates isoproterenol-induced cardiac hypertrophy by regulating myocardial remodeling and oxidative stress

    by Sanaa H. Elsayed, Nagui H. Fares, Samar H. Elsharkawy, Yomna I. Mahmoud

    Cardiovascular diseases, the leading global cause of death, are usually associated with cardiac hypertrophy (CH). CH is an adaptive response of the heart against cardiac overloading, but continuous CH accelerates cardiac remodeling and results in heart failure. Available CH therapies delay the progress of heart failure, but they often fail to control symptoms or restore quality of life. Although flaxseed lignans have been shown to have significant anti-oxidant, anti-hypertensive, anti-inflammatory, and anti-fibrotic effects in various cardiovascular diseases, little is known about their effect on CH. Thus, this study evaluated the therapeutic effect of flaxseed lignans on CH, which was induced by subcutaneous injections with isoproterenol (5 mg/kg b.w) for 14 consecutive days. Flaxseed lignans (200 mg/kg) was given orally for 4 weeks. Cardiac pathological remodeling was evaluated by echocardiography, after which morphometric, biochemical, histological, and ultrastructural analyses were performed. Flaxseed lignans significantly ameliorated CH structural and functional alterations as shown by echocardiography. Lignans also reduced the relative heart weight, significantly decreased the elevated CK-MB and the lipid peroxidation marker malondialdehyde, augmented the myocardial total antioxidant capacity, and ameliorated the histopathological and ultrastructural changes in cardiac tissues and prevented interstitial collagen deposition. The results demonstrate promising anti-hypertrophic effect of flaxseed lignans against isoproterenol-induced cardiac hypertrophy, via regulating myocardial remodeling and oxidative stress. Therefore, lignans could be used as potential pharmacological intervention in the management of CH.


  • Calanus oil attenuates isoproterenol-induced cardiac hypertrophy by regulating myocardial remodeling and oxidative stress

    by Shrook Y. Abdellatif, Nagui H. Fares, Samar H. Elsharkawy, Yomna I. Mahmoud

    Calanus oil, an oil extracted from the marine crustacean Calanus finmarchicus, is one of the richest sources of omega-3 and poly-unsaturated fatty acids. Although calanus oil has been shown to have a significant anti-hypertensive, anti-inflammatory, anti-fibrotic and anti-obesity effects in various cardiovascular diseases, but little is known about its effect on pathological cardiac hypertrophy. Thus, the present study was carried out to evaluate the therapeutic effect of calanus oil on cardiac hypertrophy. Cardiac hypertrophy was induced by subcutaneous injections with isoproterenol (5 mg/kg b.w) for 14 consecutive days. Calanus oil (400 mg/kg) was given orally for 4 weeks. Cardiac pathological remodeling was evaluated by echocardiography, after which morphometric, biochemical, histological and ultrastructural analyses were performed. Calanus oil treatment significantly ameliorated isoproterenol-induced structural and functional alterations in echocardiography. Calanus oil also reduced the relative heart weight, significantly decreased the elevated cardiac enzymes (LDH and CK-MB) and the lipid peroxidation marker (MDA), augmented the myocardial antioxidant status (TAC), and ameliorated the histopathological and ultrastructural changes in cardiac tissues and prevented interstitial collagen deposition. The present study, for the first time, provided morphometric, biochemical, histological and ultrastructural evidences supporting the promising anti-hypertrophic effect of calanus oil against ISO-induced cardiac hypertrophy. This anti-hypertrophic effect of calanus oil is via regulating myocardial remodeling and oxidative stress. Therefore, it could be used as potential pharmacological intervention in the management of cardiac hypertrophy.


  • Open Access

    Possible ameliorating effect of isoquercetin on diethylnitrosamine-induced hepatocellular carcinoma in albino mice

    by Kholoud A. Omran, Yomna I. Mahmoud, Asmaa A. Mahmoud, Nagui H. Fares

    The majority of cases of liver cancer are discovered late in the disease’s progression, making it the third leading cause of cancer death globally. Chemotherapy is the major treatment choice for advanced stages of hepatocellular carcinoma (HCC); however, drug resistance, adverse effects, and high cost are major problems for effective treatment. Isoquercetin (IQ) is a dietary flavonoid, which has an anti-proliferative effect against several cancer cell lines. It also has a prophylactic effect against the early stages of some cancer models including HCC. The purpose of this study was to assess the therapeutic anticarcinogenic effect of IQ against murine HCC. A single intraperitoneal (ip) dose of 100 mg/kg of diethylnitrosamine (DEN), followed by 18 weekly ip doses of 0.5 mg/kg of carbon-tetrachloride (CCl4) was used to induce HCC. After the induction of HCC, IQ (10 and 20 mg/kg bw) was given orally from week 21 to week 24. IQ most likely ameliorated the structure and function of livers with experimentally induced HCC by improving the survival rate, significantly reducing tumor marker alpha-fetoprotein (AFP), number of hepatic nodules and downstaging HCC. This was accompanied by an increase in endogenous antioxidant capacity and the tumor suppressor protein ‘p53’, as well as lower levels of the lipid peroxidation marker malondialdehyde (MDA), proliferation marker proliferating cell nuclear antigen (PCNA) and angiogenesis marker vascular endothelial growth factor (VEGF) in the tissues. IQ suppresses proliferation, oxidative stress, and angiogenesis in advanced HCC by activating the tumor suppressor protein p53 and inhibiting proliferation, oxidative stress, and angiogenesis.


  • Effects of subacute 3-monochloropropane-1,2-diol treatment on the kidney of male albino rats

    by Y. I. Mahmoud, F. S. Abo-Zied, S. T. Salem

    3-Monochloropropane-1,2-diol (3-MCPD) is a well-known food contaminant. Although the kidney is thought to be a target organ for 3-MCPD toxicity, nephrotoxic structural changes are relatively unstudied. We investigated the renal alterations caused by 3-MCPD in male albino rats. 3-MCPD was administered orally, at a dose of 60 mg/kg for 7 days. 3-MCPD caused significant elevation of serum creatinine and urea levels together with hydropic degeneration, necrosis and shedding of the cells of the proximal convoluted tubules, urinary casts in the distal convoluted tubules and interstitial inflammatory cell infiltration. Administration of 3-MCPD for a period as short as 7 days causes acute renal failure in male albino rats.


  • Epididymal ultrastructural changes associated with chronic cholestasis after bile duct ligation in adult rats

    by Yomna I. Mahmoud, Faten S. Abo-Zeid

    Testicular atrophy and testesterone insufficiency have been commonly reported associated with chronic liver diseases. Though testosterone dependent, the epididymal changes induced by liver disease have never been studied before. Thus, this study aimed to assess the ultrastructural events in the epididymis of rats with chronic obstructive jaundice. Chronic cholestasis induced many epididymal structural alterations manifested by the reduced tubular diameters, thickening of the tubular basement membrane, and regression of the principal cells. This was accompanied with reduction of principal cell organelles, cytoplasmic vacuolations, nuclear alterations, and stereovilli loss. The results establish that chronic cholestasis causes epididymal structural changes due to androgen deficiency.


  • Effect of dehydroepiandrosterone on the liver of perimenopausal rat: multiple doses study

    by Yomna I. Mahmoud, Asmaa A. Mahmoud, Faten S. Abo-Zeid, Nagui H. Fares

    Dehydroepiandrosterone (DHEA) is a widespread nutritional “anti-aging” supplement. Exogenous supplementation of DHEA is now being commonly used to augment ovarian stimulation in perimenopausal women with diminished ovarian reserve. Whether DHEA causes side effects in such age is, however, unknown. Thus, this study investigates the effects of pharmacological doses of DHEA supplementation on the liver of perimenopausal rats. DHEA supplementation to perimenopausal rats resulted in slight hepatomegaly and steatosis, hepatocytic hypertrophy, mitochondrial swelling, elevation in serum alanine aminotransaminase levels, in addition to the accumulation of lipid droplets and lipolysosomes in a dose-dependent manner. In conclusion, long-term administration of high doses of DHEA causes ultrastructural alterations and changes in the levels of cholesterol and triglyceride in hepatocytes of perimenopausal rats. DHEA at a dose of 50 mg/kg improves health and decreases the body weight, with the least side effects on the liver of perimenopausal rats.


  • Chronic cholestasis is associated with hypogonadism and premature ovarian failure in adult rats (cholestasis causes ovarian hypogonadism)

    by Yomna I. Mahmoud

    Hypogonadism is a well-known complication in males with chronic liver diseases. However, the consequences of chronic hepatopathies on female reproductive capacities have received relatively little attention. The present study evaluates the effect of chronic obstructive jaundice on the ovary of adult cycling rats. Estrous cyclicity was monitored to check the functional status of the hypothalamic–pituitary–ovarian axis. Ovarian changes were assessed using histomorphometric, immunohistochemical, and ultrastructural techniques. Chronic cholestasis was associated with estrous cycle irregularities, diminished ovarian weight, primordial follicle loss, atretic follicle prevalence, marked stromal fibrosis, and diminished immunoexpression of proliferation marker and estrogen receptors, in addition to many ultrastructural alterations in theca, granulosa cells, and oocytes of antral follicles. The results establish that chronic cholestasis causes hypogonadism and premature ovarian insufficiency in adult cycling female rats.